Download presentation
Presentation is loading. Please wait.
Published byDorcas Stewart Modified over 9 years ago
1
Multipartite “College Nuclear Medicine” (Founded in October 2004) A) General aim: “Role of Nuclear Medicine (Molecular) Imaging in Evidence Based Medicine” B) Specific targets: Quality assurance Technical (FANC) Clinical Clinical integration Radioprotection PET Therapy Education Structure of “working groups” Wednesday 24/11/2004
2
Members of the College Dr Jean-Paul Léonard Dr Luc Mortelmans Dr Stanislas Pauwels Dr Luc Kiebooms
3
NUCLEAR IMAGING in EVIDENCE BASED MEDICINE Guidelines – Standardisation – Quality Ass. (technical) Evidence based medicine (clinical) Clinical pathways Care programmes Cost-benefit
4
Why working groups Aim: bringing people together with: The same interest Experience or young enthousiasm Focussed topic Focussed time frame Communicate with the “nuclear community”, “clinicians” and “radiologists”.
5
Quality control and quality assurances Guidelines: Standardisation –Technical (how to do) –Clinical (when to do) Data collection –Litterature – CEBAM –Experience –Clinical database Peer review Visitation ISO certification –Workgroup –2 centers already recognised
6
Clinical guidelines! (2005) “Interaction of working groups” with “clinicians” Each group defines its own clinical indications. Discussions with clinicians via “colleges”.
7
PET Clinical guidelines (cfr. report L. Mortelmans PET onco group) PET databank (started 01/09/2003) Clinical PET research in Belgium Reimbursement: FDG Hospital fee PET center Belgian strategy PET Centers
8
“Radionuclide therapy” –Actual applications: Iodide Pain palliation MIBG … –New applications: Peptides Monoclonal antibodies …
9
Education in Nuclear Medicine Medical students Residents in training: interuniversity course Postgraduate courses Training technologists Education in medical physics and radiopharmacy Belgian Society of Nuclear Medicine –4 meetings per year –Bi-annual congress –Dedicated meetings
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.